梅斯医学参与第二十六届亚太肝病学年会全面报道
2017-02-06 MedSci MedSci原创
会议背景第二十六届亚太肝病学年会将于 2017 年 2 月 15～19 日在上海国际会议中心隆重召开，届时将会有亚太以及世界知名肝病领域专家和学者做精彩的演讲。大会三天的核心课程将总览肝病学的各项议题，其中的 State-of-the-Art 演讲将围绕着最新的肝病课题。此外，继续教育课程和晨早研习班将针对个别课题作出深入的探讨。大会主席侯金林，现任亚太肝病学会主席，中华医学会感染病学会主任委
会议背景
第二十六届亚太肝病学年会将于 2017 年 2 月 15～19 日在上海国际会议中心隆重召开，届时将会有亚太以及世界知名肝病领域专家和学者做精彩的演讲。
大会三天的核心课程将总览肝病学的各项议题，其中的 State-of-the-Art 演讲将围绕着最新的肝病课题。此外，继续教育课程和晨早研习班将针对个别课题作出深入的探讨。
大会主席侯金林，现任亚太肝病学会主席，中华医学会感染病学会主任委员，南方医科大学南方医院肝病中心主任。
会议亮点
豪华讲者团队、丰富的学术课程、近 200 个口头报告机会、近 100 个各类奖项、继续教育课程、State-of-the-Art、晨早交流班、壁报要求。
会议日程
Day 1
15 Feb 2017 (Wed)
Yellow River Hall
09:00-11:25 APASL-AASLD Joint Workshop
Session 01
How Does Clinical Research Help Patients:
Design and Data
11:25-12:55 APASL-AASLD Joint Workshop
Meet-the-Professor Luncheon
12:55-15:00 APASL-AASLD Joint Workshop
Session 02
Tips for Successful Publication
15:15-18:30 APASL-EASL Joint Workshop
3D
15:00-17:00 APASL-AASLD Joint Workshop
Break-out Session (Group 1)
3E
09:00-15:00 APASL - NGOs Joint Forum
15:00-17:00 APASL-AASLD Joint Workshop
Break-out Session (Group 2-3)
3G
15:00-17:00 APASL-AASLD Joint Workshop
Break-out Session (Group 2-3)
Day 2
16 Feb 2017 (Thu)
Grand Ballroom II
08:00-09:00 IAC-APASL
09:00-10:30 Postgraduate Course 01
Understanding Liver Cirrhosis with Emerging Concept
10:30-11:00 Coffee Break
11:00-12:15 Postgraduate Course 2
Treatments as Prevention of Liver Cirrhosis from Etiological Aspect
12:30-14:00 Lunch Symposium
14:15-15:30 Postgraduate Course 03
Multidisciplinary Approach for the Management of Portal Hypertension: New Technique and Technology
15:30-16:00 Coffee Break
16:00-17:30 Postgraduate Course 04
Expertise to Manage Complications of Liver Cirrhosis
18:00 - 19:30 Dinner Symposium
Grand Ballroom III
09:00-10:45 Basic Science Course 01
Recent Remarkable Progress:
Inflammation and the Liver
10:45-11:15 Coffee Break
11:15-12:15 Basic Science Course 02
Recent Remarkable Progress:
Accumulation of Bile, Fat and Iron in the Liver
12:30-14:00 Lunch Symposium
14:15-15:15 Basic Science Course 03
Anti Liver-Disease-Progression:
Repair, Reduce and Restore
15:15-15:45 Coffee Break
15:45-17:30 Basic Science Course 04
New Targets and Novel Therapies
18:00-19:30 Dinner Symposium
Yellow River Hall
09:00-10:30 Liver Transplant Course 01
Selection In Liver Transplantation
10:30-11:00 Coffee Break
11:00-12:15 Liver Transplant Course 02
Liver Transplant Centers
- Trend and Challenges In 2017
12:30-14:00 Lunch Symposium
14:15-15:30 Liver Transplant Course 03
Multidisciplinary Management of
Liver Transplantation Patients
15:30-16:00 Coffee Break
16:00-17:30 Liver Transplant Course 04
Multidisciplinary Management of
Liver Transplantation Patients
18:00-19:30 Dinner Symposium
Auditorium
08:00-09:30 APASL -IAC Joint Symposium
12:30-14:00 APASL-WHO Joint Symposium 01
Elimation of Viral Hepatitis
14:00-15:30 APASL-WHO Joint Symposium 02
Methodology Test
16:00-17:30 Coffee Break
13:45-15:15 APASL-WHO Joint Symposium 03
MTCT
18:00-19:30 Dinner Symposium
Day 3
17 Feb 2017 (Fri)
Grand Ballroom I
08:00-08:30 Opening Ceremony
08:30-09:00 Presidential Lecture
09:00-09:30 Keynote Lecture 1
12:00-13:30 Lunch Symposium
15:45-17:15 Plenary Presentation 01
Clinical
17:30-19:00 Dinner Symposium
Auditorium
10:00-11:30 Concurrent Session 01
Biomarkers for HBV Diagnosis and ON-Treatment Monitoring
12:00-13:30 Lunch Symposium
13:45-15:15 Concurrent Session 04
Current Status of HBV Management: Unmet Needs and Barriers
17:30-19:00 Dinner Symposium
Grand Ballroom II
10:00-11:30 Concurrent Session 02
Liver Failure:
Immediate And Specific Management
13:45-15:15 Concurrent Session 05
Molecular Mechanisms Of Livcer Fibrosis:
Diagnosis And Management
Grand Ballroom III
08:30-09:00 State-of the Art 01
09:00-09:30 State-of the Art 02
10:00-11:30 Concurrent Session 03
Inflammation, Microenvironment And Cancer Development
13:45-15:15 Concurrent Session 06
Cancer Stem Cell And HCC
Yellow River Hall
10:00-11:30 Clinical Science Course 01
Non-Viral Liver Diseases
12:00-13:30 Lunch Symposium
13:45-15:15 Clinical Science Course 02
HCV - ‘Ideal’ HCV Regimen
5B+C
10:00-11:30 Special Interest Group 01
Cell-Based Immunotherapy for Liver Diseases
13:45-15:15 Special Interest Group 03
GWAS
15:45-17:15 Oral Presentation 01
17:30-19:00 Dinner Symposium
5D+E
10:00-11:30 Special Interest Group 02
Drug Induced Liver Disease and Liver Protection
13:45-15:15 Special Interest Group 04
Non Invasive Assessment Portal Hypertension
15:45-17:15 Oral Presentation 02
17:30-19:00 Dinner Symposium
5F
15:45-17:15 Oral Presentation 03
5H
15:45-17:15 Oral Presentation 04
5I
15:45-17:15 Oral Presentation 05
5J
15:45-17:15 Oral Presentation 06
Yangtze River Hall
11:30-13:30 Poster Presentation
15:15-17:15 Poster Presentation
Day 4
18 Feb 2017 (Sat)
Grand Ballroom I
07:30-08:30 NGO Forum Report
08:30-09:00 Keynote Lecture 02
09:00-09:30 Keynote Lecture 03
12:00-13:30 Lunch Symposium
15:45-17:15 Plenary Presentation 2 Basic
17:30-19:00 Dinner Symposium
Auditorium
10:00-11:30 Concurrent Session 07
Management of HCV in Asia:
Today and Tomorrow
13:45-15:15 Concurrent Session 10
Science and Technology for Unreaqsolver Issues in HCV
17:30-19:00 Dinner Symposium
Grand Ballroom II
10:00-11:30 Concurrent Session 08
Knowledge for the Clinical Management of
Inherited Liver Disease
13:45-15:15 Concurrent Session 11
Knoeledge for the Clinical Management of Autommune Liver Disease
Grand Ballroom III
08:00-08:30 State-of the Art 03
08:30-09:00 State-of the Art 04
09:00-09:30 State-of the Art 05
10:00-11:30 Concurrent Session 09
Current Clinical Practice in HCC Therapy:
Considerations And Rationale
13:45-1515 Concurrent Session 12
New Concept And Therapy for Liver Cancer
10:00-11:30 Clinical Science Course 03
Fatty Liver - Molecular Targets and Therapeutic Strategies
12:00-13:30 Lunch Symposium
13:45-15:15 Clinical Science Course 04
Liver Fibrosis - Translation from Experimental Study into Treatment
5B+C
07:30-08:15 Morning Session 1-6
10:00-11:30 Special Interest Group 05
12:00-13:30 Lunch Symposium
13:45-15:15 Special Interest Group 07
15:45-17:15 Oral Presentation 07
5D+E
10:00-11:30 Special Interest Group 06
Extracellular Vesicles in Liver Biology
13:45-15:15 Special Interest Group 08
Paediatric Hepatology
15:45-17:15 Oral Presentation 08
15:45-17:15 Oral Presentation 09
5H
15:45-17:15 Oral Presentation 03
5I
15:45-17:15 Oral Presentation 03
5J
15:45-17:15 Oral Presentation 03
Yangtze River Hall
09:30-10:00 Poster Viewing
11:30-13:30 Poster Presentation
15:15-17:15 Poster Presentation
Day 5
19 Feb 2017 (Sun)
Trend and Challenges of HCC in Asia
13:45-15:15 Young Investigator Presentation
15:30-16:00 Closing Ceremony
07:30-08:30 General Body Meeting
08:30-09:00 Keynote Lecture 04
09:00-09:30 Keynote Lecture 05
10:00-11:30 Concurrent Session 13
Viral Hepatitis and Co-Infection
08:00-08:30 State-of the Art 06
08:30-09:00 State-of the Art 07
09:00-09:30 State-of the Art 08
10:00-11:30 Concurrent Session 14
Globalization of Fatty Liver:
Nafld in Asia Pacific Region
Yellow River Hall
10:00-11:30 Clinical Science Course 05
Liver Cancer - HCC Signaling
11:45-13:15 Clinical Science Course 06
HBV - Concept and Development of Dorect Acting Agents (DAAs)
13:30-15:00 Clinical Science Course 07
HBV - Concept and Development of Host Targeting Agents (HTAs)
5B+C
07:30-08:15 Morning Session 7-12
10:00-11:30 Oral Presentation 13
11:45-15:15 Special Interest Group 09
CRO Interaction
15:45-17:15 Special Interest Group 11
Mobile Medcine
5D+E
10:00-11:30 Oral Presentation 14
11:45-15:15 Special Interest Group 10
15:45-17:15 Special Interest Group 12
qFibrosis
5F
10:00-11:30 Oral Presentation 15
5H
10:00-11:30 Oral Presentation 16
5I
10:00-11:30 Oral Presentation 17
5J
11:30-13:30 Poster Presentation
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
#亚太#
70
好文，值得点赞，值得拥有，值得收藏！
101
#梅斯#
67
多了解还是好的
100
一看就是精彩的演讲
103